Respiratory syncytial virus (RSV) is the leading cause of hospitalisation for respiratory infection in young children.

Dr. Tedros Adhanom Ghebreyesus on how we must prepare now to counter the threat of a future pandemic.

We describe the evolution of the outbreak of Highly Pathogenic Avian Influenza (HPAI) A(H5N1) in sea lions (Otaria flavescens) of South America.

In 2020, the world was hit by the worst pandemic of our generation. At the heart of the European Commission’s response to COVID-19 were cooperation and solidarity.

Conclusions by Peter Openshaw, Co-Chair of the the ESWI Respiratory Virus Summit 2024

How to ensure/prepare for access to immunisation programmes

By Ab Osterhaus, Host of the ESWI Respiratory Virus Summit 2024

Live attenuated vaccines; NIRSE-GAL: Evaluation of the effectiveness and impact of Nirsevimab in Galicia; and Therapeutics

ESWI Summit 2024: Early Career Scientists They each delivered a presentation introducing themselves and their ongoing work on RSV, bringing innovative ideas and making clear calls for action.

Keynote Lecture by Dexter Wiseman, Imperial College London

Keynote Lecture by Stefan Gravenstein, Brown University

Keynote Lecture by Simon Drysdale, St George's University Hospitals NHS Foundation Trust